NWAM LLC’s Merck MRK Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q1 | $1.3M | Buy |
10,847
+285
| +3% | +$32.9K | 0.08% | 245 |
|
|
2025
Q4 | $1.13M | Sell |
10,562
-72
| -0.7% | -$6.76K | 0.06% | 258 |
|
|
2025
Q3 | $912K | Sell |
10,634
-753
| -7% | -$62K | 0.05% | 297 |
|
|
2025
Q2 | $892K | Sell |
11,387
-826
| -7% | -$65.7K | 0.05% | 285 |
|
|
2025
Q1 | $1.1M | Sell |
12,213
-1,371
| -10% | -$128K | 0.09% | 195 |
|
|
2024
Q4 | $1.35M | Buy |
13,584
+142
| +1% | +$14.6K | 0.08% | 220 |
|
|
2024
Q3 | $1.53M | Sell |
13,442
-1,746
| -11% | -$207K | 0.09% | 207 |
|
|
2024
Q2 | $1.88M | Buy |
15,188
+525
| +4% | +$67.6K | 0.55% | 33 |
|
|
2024
Q1 | $1.92M | Sell |
14,663
-840
| -5% | -$104K | 0.15% | 136 |
|
|
2023
Q4 | $1.69M | Sell |
15,503
-538
| -3% | -$55.8K | 0.14% | 147 |
|
|
2023
Q3 | $1.65M | Sell |
16,041
-2,243
| -12% | -$242K | 0.17% | 122 |
|
|
2023
Q2 | $2.11M | Buy |
18,284
+120
| +0.7% | +$13.6K | 0.17% | 123 |
|
|
2023
Q1 | $1.93M | Sell |
18,164
-1,576
| -8% | -$170K | 0.2% | 118 |
|
|
2022
Q4 | $2.19M | Sell |
19,740
-469
| -2% | -$47.9K | 0.19% | 119 |
|
|
2022
Q3 | $1.74M | Sell |
20,209
-340
| -2% | -$30.4K | 0.17% | 128 |
|
|
2022
Q2 | $1.9M | Sell |
20,549
-718
| -3% | -$63.7K | 0.18% | 121 |
|
|
2022
Q1 | $1.75M | Buy |
21,267
+2,797
| +15% | +$221K | 0.13% | 154 |
|
|
2021
Q4 | $1.42M | Buy |
18,470
+3,328
| +22% | +$265K | 0.11% | 193 |
|
|
2021
Q3 | $1.14M | Sell |
15,142
-1,523
| -9% | -$116K | 0.1% | 206 |
|
|
2021
Q2 | $1.3M | Sell |
16,665
-1,384
| -8% | -$103K | 0.12% | 174 |
|
|
2021
Q1 | $1.33M | Sell |
18,049
-252
| -1% | -$18.6K | 0.13% | 169 |
|
|
2020
Q4 | $1.43M | Buy |
18,301
+492
| +3% | +$37.6K | 0.16% | 141 |
|
|
2020
Q3 | $1.41M | Buy |
17,809
+564
| +3% | +$44.2K | 0.23% | 104 |
|
|
2020
Q2 | $1.27M | Buy |
17,245
+1,464
| +9% | +$110K | 0.18% | 124 |
|
|
2020
Q1 | $1.16K | Buy |
15,781
+3,187
| +25% | +$250K | 0.03% | 141 |
|
|
2019
Q4 | $1.09M | Buy |
12,594
+158
| +1% | +$13K | 0.19% | 116 |
|
|
2019
Q3 | $999K | Buy |
12,436
+140
| +1% | +$11.2K | 0.19% | 116 |
|
|
2019
Q2 | $984K | Sell |
12,296
-104
| -0.8% | -$7.96K | 0.2% | 112 |
|
|
2019
Q1 | $984K | Sell |
12,400
-96
| -0.8% | -$7.18K | 0.21% | 102 |
|
|
2018
Q4 | $911K | Buy |
12,496
+1,546
| +14% | +$109K | 0.23% | 99 |
|
|
2018
Q3 | $741K | Buy |
10,950
+72
| +0.7% | +$4.59K | 0.17% | 133 |
|
|
2018
Q2 | $630K | Sell |
10,878
-220
| -2% | -$12.4K | 0.15% | 150 |
|
|
2018
Q1 | $577K | Sell |
11,098
-1,485
| -12% | -$80.2K | 0.15% | 154 |
|
|
2017
Q4 | $676K | Sell |
12,583
-1,141
| -8% | -$63.3K | 0.17% | 132 |
|
|
2017
Q3 | $838K | Sell |
13,724
-788
| -5% | -$47.8K | 0.22% | 111 |
|
|
2017
Q2 | $887K | Buy |
14,512
+1,912
| +15% | +$116K | 0.15% | 104 |
|
|
2017
Q1 | $764K | Buy |
12,600
+1,703
| +16% | +$103K | 0.23% | 103 |
|
|
2016
Q4 | $612K | Buy |
10,897
+781
| +8% | +$45.7K | 0.2% | 123 |
|
|
2016
Q3 | $602K | Buy |
10,116
+1,299
| +15% | +$76K | 0.05% | 124 |
|
|
2016
Q2 | $485K | Buy |
8,817
+549
| +7% | +$29.2K | 0.19% | 118 |
|
|
2016
Q1 | $417K | Sell |
8,268
-1,589
| -16% | -$77.8K | 0.17% | 133 |
|
|
2015
Q4 | $497K | Buy |
+9,857
| New | +$497K | 0.2% | 111 |
|
|
2015
Q2 | – | Sell |
-8,868
| Closed | -$486K | – | 267 |
|
|
2015
Q1 | $486K | Buy |
8,868
+293
| +3% | +$16.6K | 0.21% | 123 |
|
|
2014
Q4 | $465K | Sell |
8,575
-11,754
| -58% | -$655K | 0.2% | 123 |
|
|
2014
Q3 | $1.15M | Sell |
20,329
-22,961
| -53% | -$1.29M | 0.41% | 69 |
|
|
2014
Q2 | $2.39M | Buy |
43,290
+1,214
| +3% | +$66.2K | 0.74% | 37 |
|
|
2014
Q1 | $2.28M | Buy |
42,076
+10,854
| +35% | +$562K | 0.78% | 37 |
|
|
2013
Q4 | $1.49M | Sell |
31,222
-7,264
| -19% | -$332K | 0.79% | 46 |
|
|
2013
Q3 | $1.75M | Buy |
38,486
+888
| +2% | +$40.5K | 0.85% | 40 |
|
|
2013
Q2 | $1.67M | Buy |
+37,598
| New | +$1.68M | 0.84% | 44 |
|
Other funds holding MRK
VCM
VPM
NWAM LLC's MRK Position: Q1 2026 in Review
NWAM LLC increased its Merck (MRK) stake by 2.7% in Q1 2026, buying an estimated $32.9K and bringing the position to 10,847 shares worth $1.3M. The position accounts for 0.08% of the portfolio, ranked #245.
NWAM LLC first reported a position in MRK in Q2 2013 and has held it in 50 quarters since. The position peaked at $2.39M in Q2 2014. 3,775 funds tracked by Wall St. Rank hold MRK as of Q1 2026.
- NWAM LLC held 10,847 shares of Merck worth $1.3M as of Q1 2026.
- NWAM LLC bought 285 Merck shares in Q1 2026, an estimated $32.9K.
- Merck made up 0.08% of NWAM LLC's portfolio in Q1 2026, its #245 holding.
- NWAM LLC first reported a position in Merck in Q2 2013 and has held it in 50 quarters since.
- NWAM LLC's Merck position peaked at $2.39M in Q2 2014.
- 3,775 funds tracked by Wall St. Rank held Merck as of Q1 2026.
Based on NWAM LLC's 13F filing for Q1 2026, filed 4 May 2026.